Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 19, 2024

SELL
$1.14 - $1.81 $16,530 - $26,245
-14,500 Closed
0 $0
Q2 2023

Apr 22, 2024

SELL
$1.79 - $4.59 $28,640 - $73,440
-16,000 Closed
0 $0
Q1 2023

Apr 22, 2024

BUY
$2.84 - $3.92 $45,440 - $62,720
16,000 New
16,000 $62.2 Million
Q4 2022

Apr 19, 2024

BUY
$2.48 - $5.93 $35,960 - $85,985
14,500 New
14,500 $49.3 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $66.2M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Ashton Thomas Private Wealth, LLC Portfolio

Follow Ashton Thomas Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.